VXRT
Vaxart Inc
0.449$
-1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +54.5% | -32.8% | +193.5% | -22.9% | +207.8% | +37.5% | +90.3% | +82.3% | +44.0% | -62.4% | -30.7% | – | |
| – | +0.0% | -8.3% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | +127.0% | +6.7% | +193.5% | -22.9% | +207.8% | +37.5% | +90.3% | +82.3% | +44.0% | -62.4% | -30.7% | – | |
| – | -2.0% | +29.3% | -8.1% | -13.8% | +50.4% | +35.7% | +61.8% | +52.7% | -40.6% | -34.9% | +14.8% | – | |
| – | +10.5% | +33.1% | -28.5% | -16.1% | -7.3% | +26.0% | -9.3% | -7.0% | -14.3% | +26.6% | +42.3% | – | |
| – | +1.2% | +38.6% | -13.7% | -14.3% | +37.5% | +34.2% | +51.7% | +47.7% | -39.2% | -30.2% | +18.5% | – | |
| – | – | – | – | – | – | – | – | – | – | -90.7% | -354.6% | – | |
| – | +322.2% | -8.0% | -24.1% | +3.4% | +46.4% | +7.9% | -32.6% | -9.5% | -10.2% | -7.5% | +6.5% | – | |
| – | – | – | – | – | – | – | – | – | – | -90.6% | -358.5% | – | |
| – | +346.2% | -74.1% | -53.3% | -14.3% | +877.8% | -46.0% | -78.9% | -15.0% | +1,923.5% | -91.6% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -90.6% | -360.6% | – | |
| – | – | – | – | – | – | – | – | – | – | -88.2% | -278.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.